Tews, Hauke Christian
Huss, Muriel
Elger, Tanja
Liebisch, Gerhard
Höring, Marcus
Loibl, Johanna
Kandulski, Arne
Müller, Martina
Buechler, Christa
Funding for this research was provided by:
Universitätsklinikum Regensburg
Article History
Received: 22 June 2025
Accepted: 31 January 2026
First Online: 4 February 2026
Declarations
:
: The study was approved by the Ethics Committee of the University Hospital Regensburg (protocol no. 19-1309-101, approval date: 20.02.2019), and all participants provided written informed consent. The study was conducted in accordance with the updated guidelines for good clinical practice and the updated Declaration of Helsinki.
: Not applicable.
: AK declares following disclosures: scientific presentations and scientific advisory: Roche Pharma AG, Eisai GmbH, AbbVie Germany AG, Janssen-CilagGmbH, MSD Sharp&DohmeGmbH, Boston Scientific Corp., Fujifilm Germany, Micro-Tech Germany, Bayer Pharma AG Germany, AstraZeneca GmbH, M. M. declares the following disclosures: Travel grants from United European Gastroenterology (UEG), travel grants, scientific advisory, scientific presentations: AbbVie Germany, Gilead Sciences, Ipsen All other authors have no competing interests.